Alaa H. Falemban

Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study

S. Al-Ghamdi, A. Alzahrani, N. Ayoub, 2022, Journal of clinical medicine.

Medication Adherence among Patients with Chronic Diseases in Saudi Arabia

H. Alwafi, A. Alshanberi, Y. Alhindi, 2022, International journal of environmental research and public health.

COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications

I. Shahid, S. Al-Ghamdi, Z. Almalki, 2023, International immunopharmacology.

Phenotypic variability to medication management: an update on fragile X syndrome

I. Abumansour, Imad A Aljahdali, N. Elhawary, 2023, Human Genomics.

COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications

I. Shahid, S. Al-Ghamdi, Z. Almalki, 2023, International Immunopharmacology.

Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study

G. Bamagous, Y. Alhindi, N. Ayoub, 2023, Journal of clinical medicine.

Toxicity of Nab-Paclitaxel Compared to Paclitaxel in a Tertiary Hospital in Jeddah, Saudi Arabia: A Retrospective Cohort Study

G. Bamagous, Y. Alhindi, N. Ayoub, 2023, Cureus.

Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia

S. Al-Ghamdi, Y. Alhindi, A. Alzahrani, 2023, Journal of clinical medicine.

Patterns of Caffeine Consumption in Western Province of Saudi Arabia

H. Alwafi, S. A. Ansari, A. Alshanberi, 2022, Pharmacognosy Research.